Research on the Pathogenesis and Therapeutic Targets of Articular Cartilage Degeneration in Osteoarthritis
1 other identifier
observational
30
1 country
1
Brief Summary
Before you are included in this study, you will undergo the following examinations to determine if you are eligible to participate: Before you are included in this study, your doctor will ask and record your medical history, conduct a physical examination on you, and perform necessary imaging tests. 2. If you are more than qualified examination, will study according to the following steps: if you meet the inclusion criteria, will study according to the following steps: (1) when you accept total knee replacement, the doctor will collect a small piece of articular cartilage (0.5 cm x 0.5 cm x 0.5 cm) used for research and analysis. (2) The process of collecting tissue specimens will be carried out by experienced orthopedic doctors, and the entire process will take approximately 5 to 10 minutes. One week and two weeks after the operation, the doctor will follow up with you to understand your recovery progress. 3, other matters need your cooperation: please timely follow-up to the hospital after the operation, so that the doctor evaluate your recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2026
CompletedFirst Submitted
Initial submission to the registry
April 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
CompletedFirst Posted
Study publicly available on registry
September 1, 2026
CompletedSeptember 1, 2026
August 1, 2026
7 months
April 18, 2026
August 28, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Cell Morphology Assessed by Transmission Electron Microscopy
Qualitative assessment of overall cell morphology (e.g., normal, swollen, necrotic) in articular cartilage samples.
Perioperative/Periprocedural
Mitochondrial Status Assessed by Transmission Electron Microscopy
Assessment of mitochondrial ultrastructure, including membrane integrity and cristae architecture.
Perioperative/Periprocedural
Autophagosome Quantity Assessed by Transmission Electron Microscopy
Quantification of autophagosome numbers per cell in articular cartilage samples.
Perioperative/Periprocedural
Study Arms (2)
normal control
Osteoarthritis
Eligibility Criteria
The study enrolled 15 OA patients and 15 normal controls at Kunming Hospital of Traditional Chinese Medicine. All provided informed consent; basic and disease data were collected. Cartilage specimens were obtained intraoperatively by orthopedic surgeons. OA group: total knee arthroplasty patients. Normal control group: OA-free subjects from two sources: (1) femoral head replacement (Garden I/II) or knee arthroscopy for meniscal/ligament injury, and (2) traumatic lower-limb amputation. In source 1, cartilage was taken from the operated joint (hip/knee); in source 2, from the intact joint of the amputated limb. All control cartilage was confirmed Outerbridge grade 0 intraoperatively.
You may qualify if:
- Osteoarthritis group:
- Meets the American College of Rheumatology (ACR) diagnostic criteria for osteoarthritis: ① Persistent knee pain for ≥1 month; ② X-ray shows osteophytes at the knee joint margin; ③ Age ≥50 years; ④ Morning stiffness \<30 minutes; ⑤ Knee joint friction sounds. (Diagnosis requires item ① plus any two of items ②-⑤).
- Radiographic Kellgren-Lawrence (K-L) grade ≥2;
- Complete the entire treatment course without interruption or modification of the treatment plan during the process;
- Complete the full-process assessment and follow-up;
- The image and medical record materials are complete.
- Normal control group:
- Normal Control Group (subjects must meet criteria for one of the following two sources):
- (1) Source A - Non-arthritic surgery patients:
- )No history of knee osteoarthritis, rheumatoid arthritis, gouty arthritis, infectious arthritis, or other joint diseases 2)Undergoing surgery for one of the following indications:
- Femoral neck fracture (Garden type I/II) treated with artificial femoral head replacement
- Simple meniscus injury or ligament injury requiring knee arthroscopy 3)Preoperative X-ray of the joint from which cartilage will be collected shows normal joint space, K-L grade 0, and no osteophytes, subchondral sclerosis, or cystic change (hip joint for femoral head replacement; knee joint for arthroscopy) 3)Intraoperative macroscopic observation or specimen evaluation confirms smooth cartilage surface with no softening, fissure, or fibrosis (Outerbridge grade 0) 4)Complete imaging and medical records available
- Source B - Traumatic amputees:
- No history of any joint disease (knee osteoarthritis, rheumatoid arthritis, gouty, infectious arthritis, etc.)
- Undergoing amputation of a lower limb purely for traumatic reasons, with no pre-existing joint pathology in the limb to be amputated
- +3 more criteria
You may not qualify if:
- ① Combined with other types of joint diseases, autoimmune diseases or bone metabolic diseases;
- ② Has a history of drug abuse;
- ③ Those who have not signed the informed consent form;
- ④ Suffering from mental illness and unable to cooperate with research;
- ⑤ Other personnel who are not suitable to participate in the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yunnan University of Chinese Medicine
Kunming, Yunnan, 650500, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sponsor
Study Record Dates
First Submitted
April 18, 2026
First Posted
September 1, 2026
Study Start
January 29, 2026
Primary Completion
August 31, 2026
Study Completion
August 31, 2026
Last Updated
September 1, 2026
Record last verified: 2026-08